Home › Therapeutic areas › Immunology › Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (14 companies)
Companies with an active program in Systemic Lupus Erythematosus.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ACET | Adicet Bio | ImmunologyNeurology+2 Rare | 1 | Phase 1 | 8 |
| ALLO | Allogene Therapeutics | ImmunologyOncology Rare | 1 | Phase 2 | 10 |
| ARTV | Artiva Biotherapeutics | DermatologyImmunology+2 Rare | 1 | Phase 2 | 14 |
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 1 | Approved | 12 |
| CABA | Cabaletta Bio | DermatologyImmunology+2 Rare | 1 | Phase 1 | 8 |
| IPSC | Century Therapeutics | ImmunologyMetabolic+1 Rare | 2 | Phase 1 | 9 |
| CLYM | Climb Bio | HematologyImmunology+1 Rare | 2 | Phase 2 | 7 |
| CGEM | Cullinan Therapeutics | HematologyImmunology+2 Rare | 2 | NDA Submitted | 10 |
| IMVT | Immunovant | ImmunologyNeurology Rare | 1 | Phase 3 | 6 |
| INAB | IN8bio | ImmunologyOncology | 1 | Phase 2 | 6 |
| NKTR | Nektar Therapeutics | DermatologyImmunology+2 | 1 | Phase 3 | 11 |
| NKTX | Nkarta | ImmunologyNeurology+1 Rare | 1 | Phase 1 | 8 |
| XNCR | Xencor | HematologyImmunology+4 Rare | 1 | Approved | 36 |
| ZBIO | Zenas BioPharma | DermatologyImmunology+2 Rare | 1 | NDA Submitted | 11 |
No companies match.